Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

CPHI Frankfurt 2025: The Current API Market

October 28, 2025

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective on the API market and why it is important to qualify API suppliers.

Trends Shaping Radiopharmaceutical Development

October 27, 2025

Radiopharmaceuticals are allowing for the targeted treatment of cancers, but they do pose challenges.

Tara Dougal Welcomes You to CPHI Frankfurt 2025

October 26, 2025

Pharmaceutical Technology® spoke with Tara Dougal, Event Director for Pharma at Informa Markets about what attendees at CPHI Frankfurt should expect this year.

Harnessing Real-World Evidence to Future-Proof Drug Development

October 23, 2025

Real-world data can be utilized to ensure quality and effectiveness of drug products.

Challenges, Innovations, and Future Outlook of Biologics Formulations

October 22, 2025

Non-parenteral alternatives for biologics remain a clinical imperative and a formidable challenge.

The Evolving Oncology Landscape

October 22, 2025

Recent developments show how innovations and treatments for cancer are rapidly advancing.

How ALK's UK-Approved Nasal Spray Changes the R&D Model for Acute Emergency Treatment

October 20, 2025

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data comparable to injection effectiveness.

Test Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery

October 20, 2025

Take this quiz to test your comprehension of one of our recent feature articles.

Test Your Knowledge (Answers): Patient-Centric Care Through Oral Liquid Delivery

October 20, 2025

Why Radiopharmaceuticals Are Ideal for Treating Cancer

October 16, 2025

Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.